Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:clinicalTrialPhase |
Phase 1
|
| gptkbp:developedBy |
gptkb:Servier
gptkb:Allogene_Therapeutics |
| https://www.w3.org/2000/01/rdf-schema#label |
ALLO-501
|
| gptkbp:indication |
leukemia
relapsed/refractory large B-cell lymphoma |
| gptkbp:intendedUse |
gptkb:cancer
|
| gptkbp:mechanismOfAction |
gene therapy
|
| gptkbp:products |
ALLO-501A
|
| gptkbp:relatedClinicalTrial |
NCT03939026
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:status |
investigational
|
| gptkbp:target |
gptkb:CD19
|
| gptkbp:treatment |
allogeneic CAR-T
|
| gptkbp:bfsParent |
gptkb:Allogene_Therapeutics
|
| gptkbp:bfsLayer |
7
|